WDR25: A Potential Drug Target Or Biomarker (G79446)
WDR25: A Potential Drug Target Or Biomarker
WDR25 (C14orf67) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique genetic mutation has led to a gain of function in the gene, resulting in the production of a hyperactive form of the protein.
The WDR25 gene is located on chromosome 14 and is responsible for the production of a protein known as WDR25. This protein plays a crucial role in the development and maintenance of tissues, including the brain and spinal cord.
WDR25 has been shown to be involved in a number of different diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Its hyperactive form has been linked to the development of various diseases, including neurofibrillary tangles and neurodegeneration.
One of the most promising aspects of WDR25 is its potential as a drug target. By targeting the hyperactive form of the protein, researchers may be able to reduce its production and potentially slow down or stop the progression of diseases associated with its hyperactive form.
In addition to its potential as a drug target, WDR25 has also been shown to be a potential biomarker for a number of diseases. Its hyperactive form is associated with the development of neurofibrillary tangles, which are thought to play a role in the development of Alzheimer's disease.
Research has also suggested that WDR25 may be involved in the development of neurodegenerative diseases, including Parkinson's disease and Huntington's disease. By targeting this gene, researchers may be able to develop new treatments for these conditions.
Overall, the WDR25 gene has significant potential as a drug target or biomarker for a number of diseases. Further research is needed to fully understand its role in these conditions and to develop effective treatments.
Protein Name: WD Repeat Domain 25
The "WDR25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR25 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4
